PRODUCT NEWS The latest product news in healthcare

Nordic Pharma launches Dnord for the treatment of vitamin D deficiency

Nordic Pharma Ireland are pleased to announce the launch of Dnord, a prescription only treatment for vitamin D deficiency. Dnord is available in 255mcg soft gel capsules of calcifediol as calcifediol monohydrate, which come in a pack of 10. Dnord is indicated for the following:  Treatment of vitamin D deficiency in adults.  Prevention of vitamin D deficiency in adults with identified risks, such as in patients with malabsorption syndrome, chronic kidney disease mineral and bone disorder (CKDMBD), or other identified risks.  As adjuvant for the specific treatment of osteoporosis in patients with vitamin D deficiency, or at risk of vitamin D deficiency.

Dnord is a one capsule, once a month dosing for patients with vitamin D deficiency and prevention of vitamin D deficiency in patients with identified risks or adjuvant for the specific treatment of osteoporosis. Higher doses may be necessary in some patients after analytical verification of the extent of the deficiency. In those cases, the maximum dose administered should not exceed one capsule per week.

Dnord should not be administered with a daily frequency. Dnord is reimbursed under the General Medical Services and Community Drugs Scheme, and is available from 1 January 2023. Please refer to the summary of product characteristics for further information, which is available at www.hpra.ie, or from Nordic Pharma Ireland on 01 468 8998.

ACCORD HEALTHCARE IRELAND LAUNCHES ANOTHER PATIENT SUPPORT APP

Accord Healthcare Ireland is launching its new mobile app, Me & My Methofill, for patients with rheumatoid arthritis that are on methofill. Methotrexate is one of the most incorrectly dosed medicines, and the Health Products Regulatory Authority (HPRA) adopted the recommendations issued by the European Medicines Authority (EMA) to prevent serious potential errors with dosing, which included more prominent warnings on product packaging and providing educational materials for patients and healthcare providers.

The Me & My Methofill mobile app supports rheumatoid arthritis patients to take care of their own health and wellbeing, by providing weekly medication reminders to support correct dosing, how to inject animations, patient materials, and adverse event reports information.

Ms Tracy Kivlehan, Head of Hospitals and Speciality Brands, Accord Healthcare Ireland, said: “We are delighted to be rolling out our second patient-centred app to Irish patients, which continues to demonstrate our support to patients across therapy areas with app technology. This new app will allow patients prescribed methofill to help manage their self-dose treatment from the comfort of their own home. We are committed to supporting the patients and healthcare providers of Ireland, and we believe our Me & My Methofill app will do just that.”

The app is available to download free of charge from iTunes and Google Play.